| Luis Tapia, MD | |
|
200 Madison Ave, Elmira, NY 14901-3218 | |
| (607) 737-7835 | |
| (607) 737-1519 |
| Full Name | Luis Tapia |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 200 Madison Ave, Elmira, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396826244 | NPI | - | NPPES |
| 00183133 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 105018 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Luis Tapia, MD 722 W Water St, Elmira, NY 14905-2435 Ph: (607) 271-2050 | Luis Tapia, MD 200 Madison Ave, Elmira, NY 14901-3218 Ph: (607) 737-7835 |
News Archive
The BMA today welcomed the publication of two Scottish Executive reports into the education and training of the medical workforce in Scotland acknowledging that they offered many solutions but, warned that they would only be successful if the recommendations are followed and effective action is taken now.
New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of the Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.
Cardiovascular disease was the leading cause of death in Florida in 2005, accounting for approximately 35 percent of all deaths in the state. People with heart disease are at a high risk for serious and potentially life-threatening complications from the flu.
› Verified 6 days ago
Rohail Aijaz Baig, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-442-1713 | |
Dr. Franck Taghi Tirgari, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7770 Fax: 607-271-3686 | |
Dr. Samir Shah, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-4100 | |
Dr. James G. Freeman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 200 Madison Ave, 3rd Floor, Elmira, NY 14901 Phone: 607-734-1581 Fax: 607-734-0972 | |
Dr. Keith W. Parker, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 200 Madison Ave Fl 3, Elmira, NY 14901 Phone: 607-734-1581 Fax: 607-734-0972 | |
Dr. Ethan Levine, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-735-4623 Fax: 607-271-3711 | |
Dr. Samuel Thomas Jennings, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 600 Fitch St, Suite 202 & 203, Elmira, NY 14905 Phone: 607-271-3780 Fax: 607-271-3894 |